| Hodgkin's disease: the Milan Cancer Institute experience with MOPP and ABVD. | |
| | |
MedLine Citation:
|
PMID: 2481328 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
The report includes the essential therapeutic and toxic results following MOPP vs. MOPP/ABVD and MOPP vs. ABVD within a combined modality setting. The findings indicate that in stage IV the alternating regimen is superior to MOPP while in stage IIB-III ABVD plus radiotherapy yielded superior results associated with no treatment-induced sterility and leukemia compared with MOPP plus radiotherapy. |
| | |
Authors:
|
G Bonadonna; P Valagussa; A Santoro; S Viviani; V Bonfante; A Banfi |
Related Documents
:
|
17074388 - Analysis of histone modification around the cpg island region of the p15 gene in acute ... 8018608 - Transient diabetes insipidus and acute fatty liver of pregnancy. 6563518 - Maternal corticosteroid therapy and the fetal brain in experimental hyaline membrane di... 19488938 - Pregnancy after a previous gestation complicated by an acute aortic dissection. 17084398 - Conjoined twins in a trichorionic quadruplet pregnancy after intracytoplasmic sperm inj... 9398648 - The placenta is not the main source of leptin production in pregnant rat: gestational p... |
Publication Detail:
|
Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial |
Journal Detail:
|
Title: Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer Volume: 117 ISSN: 0080-0015 ISO Abbreviation: Recent Results Cancer Res. Publication Date: 1989 |
Date Detail:
|
Created Date: 1990-02-01 Completed Date: 1990-02-01 Revised Date: 2008-02-13 |
Medline Journal Info:
|
Nlm Unique ID: 0044671 Medline TA: Recent Results Cancer Res Country: GERMANY, WEST |
Other Details:
|
Languages: eng Pagination: 169-74 Citation Subset: IM |
Affiliation:
|
Divisions of Medical Oncology, Istituto Nazionale Tumori, Milan, Italy. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Antineoplastic Combined Chemotherapy Protocols
/
therapeutic use Bleomycin / administration & dosage Combined Modality Therapy Dacarbazine / administration & dosage Doxorubicin / administration & dosage Hodgkin Disease / drug therapy* Humans Mechlorethamine / administration & dosage Prednisone / administration & dosage Procarbazine / administration & dosage Randomized Controlled Trials as Topic Vinblastine Vincristine / administration & dosage |
| Chemical | |
Reg. No./Substance:
|
0/ABVD protocol; 0/MOPP protocol; 11056-06-7/Bleomycin; 23214-92-8/Doxorubicin; 4342-03-4/Dacarbazine; 51-75-2/Mechlorethamine; 53-03-2/Prednisone; 57-22-7/Vincristine; 671-16-9/Procarbazine; 865-21-4/Vinblastine |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Subcellular localization of cyclo-oxygenase-prostaglandin E2 synthetase complex in goat vesicular gl...
Next Document: Role of surgery in metastatic renal cell carcinoma.